Vimarsana
Biggest News Aggregation in the World

Page 2 - Therapeutic Development Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutic Development Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutic Development Programs Today - Breaking & Trending Today

Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by Analysts at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance Navidea Biopharmaceuticals stock opened at $0.04 on Friday. Navidea Biopharmaceuticals has a twelve month low of […]

StockNews.com Begins Coverage on Navidea Biopharmaceuticals (NYSE:NAVB) - Vimarsana News

StockNews.com Begins Coverage on Navidea Biopharmaceuticals (NYSE:NAVB)

StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NAVB opened at $0.04 on Friday. The firm has a market capitalization of $3.95 million, a price-to-earnings ratio […]

Source: wkrb13.com
Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note published on Thursday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Navidea Biopharmaceuticals stock opened at $0.04 on Thursday. The firm has a market capitalization of $4.09 million, a PE ratio of -0.68 and […]

Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Wednesday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NAVB opened at $0.06 on Wednesday. The stock has a market capitalization of $5.75 million, a price-to-earnings ratio of -0.96 and a beta of […]

Source: wkrb13.com
Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Wednesday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NYSE:NAVB opened at $0.06 on Wednesday. The firm has a fifty day simple moving average of $0.06 and a two-hundred day simple […]